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The covalent attachment of ubiquitin onto proteins can elicit a variety of downstream conse-
quences. Attachment is mediated by a large array of E3 ubiquitin ligases, each thought be sub-
ject to regulatory control and to have a specific repertoire of substrates. Assessing the
biological roles of ligases, and in particular, identifying their biologically relevant substrates has
been a persistent yet challenging question. In this study, we describe tools that may help
achieve both of these goals. We describe a strategy whereby the activity of a ubiquitin ligase
has been enzymatically reversed, accomplished by fusing it to a catalytic domain of an exoge-
nous deubiquitinating enzyme. We present a library of 72 “anti-ligases” that appear to work in
a dominant-negative fashion to stabilize their cognate substrates against ubiquitin-dependent
proteasomal and lysosomal degradation. We then used the ligase-deubiquitinating enzyme
(DUb) library to screen for E3 ligases involved in post-Golgi/endosomal trafficking. We identify
ligases previously implicated in these pathways (Rsp5 and Tul1), in addition to ligases previ-
ously localized to endosomes (Pib1 and Vps8). We also document an optimized workflow for
isolating and analyzing the “ubiquitome” of yeast, which can be used with mass spectrometry
to identify substrates perturbed by expression of particular ligase-DUb fusions.
KEYWORDS
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1 | INTRODUCTION
Ubiquitination is a posttranslational modification that controls almost
every aspect of eukaryotic cell biology, including protein degradation,
membrane trafficking, signal transduction, cell division and DNA
repair.1–3 The conjugation of Ubiquitin (Ub) to either soluble proteins
or the cytosolic portions of membrane proteins serves as a signal for
protein degradation, carried out by either the proteasome or lyso-
some.4,5 These activities maintain proper cellular levels of proteins
and also provide a quality control mechanism to clear misfolded pro-
teins.6 Different lysines within Ub itself can be ubiquitinated to cre-
ate polyubiquitin chains of different topologies, which in turn can
code for an enormous diversity in functional outcomes.7 Typically,
substrate lysine residues are conjugated to the C-terminal G76 resi-
due of Ub upon transfer from E2 conjugating enzymes that carry Ub
via a thiol-ester linkage. The vast majority of E3 ligases contain a
RING (really interesting new gene) domain and can bind E2 enzymes
to direct their activity,8 although other ligases such as HECT-type
(homologous to E6-AP carboxyl terminus) and ring-between-ring can
themselves carry the thiol-ester linked Ub intermediate.
More than 600 predicted E3 enzymes are encoded in the human
genome.9 This diversity poses difficulties for studying ubiquitination;
for example, ligase depletion/deletion experiments are often difficult
to interpret due to redundancy of multiple ligases targeting the same
substrate proteins. In addition, long-term ligase depletion/deletion
studies may allow cells to adopt various compensatory responses or
become enfeebled in the case of ligases that are essential for viability.
These issues are compounded by technical problems, as it is inher-
ently difficult to observe ubiquitinated protein species that are in the
process of being degraded, and which account for only a small
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percentage of any protein population. Furthermore, ubiquitinated
substrates are prone to deubiquitination during cell lysis procedures,
when an array of deubiquitinating enzymes, which are notoriously
difficult to inactivate, are unleashed.10 In vitro approaches have
greatly aided our understanding of the ubiquitination process, but
generally fall short in preserving the level of specificity, diversity and
sensitivity needed to identify substrate candidates.
One of the best characterized E3 ligases in yeast is Rsp5, a HECT
domain ligase of the NEDD4 (neural-precursor-cell-expressed, devel-
opmentally downregulated) ligase family, which has multiple cellular
roles.11 Rsp5 has been intensely studied and proved to be a useful
model for understanding human disease, such as alpha-Synuclein traf-
ficking12 and mechanisms driving catalysis of the NEDD4 ligases.13,14
Although many putative ligases have no known substrates, Rsp5
has been implicated in the ubiquitination of approximately
80 substrates.15–17 Rsp5 was originally identified as npi1 (nitrogen
permease inactivator 1) because of its role in downregulating cell sur-
face transporters, such as Gap1 and Fur4.18,19 Indeed, although Rsp5
has been shown to ubiquitinate proteasomal cargoes,20 its broader
function appears to be in modifying membrane proteins to provide a
sorting signal for their delivery and degradation in the vacuole. Rsp5
is essential for viability owing to its role in controlling transcription of
the enzyme required for oleic acid production.21 Loss of function
temperature-sensitive alleles have been useful tools to acutely inhibit
Rsp5; however, different alleles appear to have varying levels of
residual activity toward particular substrates.22,23 Previously, we used
an alternative approach to inhibit the function of Rsp5 that involved
fusing the catalytic domain of a deubiquitinating enzyme (DUb) to
the C-terminus of the ligase24 and place production of this fusion
protein under an inducible promoter. This dominant-negative Rsp5-
DUb antagonizes endogenous Rsp5, illustrated by stabilization of a
host of Rsp5 substrates.24
Here, we apply this principle more widely by creating a systematic
plasmid library of ligase-DUb fusion proteins. A survey of some of these
“anti-ligases” show that they antagonize the function of their endoge-
nous counterpart, and do so with the sensitivity and specificity required
to perform future functional studies. In addition, we use this panel of
antiligases to implicate new ubiquitin-dependent roles for Tul1, Pib1 and
Vps8 in the sorting of the soluble hydrolase carboxypeptidase Y (CPY) to
the vacuole. Finally, we present optimized methods and a yeast strain
for proteomic analysis of the ubiquitinated portion of the yeast prote-
ome, or “ubiquitome”. Our mass spectrometry analyses of purified
FIGURE 1 A systematic plasmid library for
reversal of yeast E3-ligase activity. A,
Schematic representation of ligase-DUb
fusion proteins. The final step in the
ubiquitination cascade involves transfer of Ub
from an E2 conjugating enzyme to a
substrate through the activity of an E3 ligase
enzyme. Substrate deubiquitination is
induced by expression of E3 ligase-DUb
fusion proteins. B, E3 ligases expressed in
wild-type cells as fusions with a C-terminal
DUb (UL36) enzyme and an Hemagglutinin
(HA) epitope. A 50 μM copper was added to
the media to induce protein expression from
the CUP1 promoter. Two transformants for
each ligase-DUb fusion were validated; a
black asterisk indicates particular fusions for
which only one Ura+ clone expresses.
Molecular weight markers are indicated. DUb,
deubiquitinating enzyme
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FIGURE 2 Phenotypic analyses of ligase-deubiquitinating enzyme (DUb) fusion library. A, Wild-type (SEY6210) yeast cells were grown to mid-
log phase in SC media lacking uracil, harvested and a 10-fold serial dilution was spotted out on plates containing different solid media. Cells
were plated on media containing 50 μM bathocupriosulfonic acid (BCSA) to repress gene expression. Cells were also plated on media lacking
copper or plasmid expression was induced on plates containing 50 μM copper chloride. These plates were incubated at 30! or 37!C. Cultures
were also plated on copper containing media lacking glucose as a primary carbon source, which were instead supplied with oleate at 30!C and
ethanol glycerol at 30! and 37!C. B, Wild-type yeast cells expressing labeled DUb fusions, or vector control, were grown to mid-log phase in
standard SC-Ura media and prepared for immunoblot analysis using anti-HA and anti-Rsp5 antibodies. Cells were also grown to mid-log phase in
minimal media and then labeled with MitoTracker for 1 hour, washed twice with water and then imaged by fluorescence microscopy. A
Normarski image is included and 5 μm scale bars are indicated
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ubiquitinated species indicate many components of the post-Golgi traf-
ficking machinery, including many Soluble N-ethylmaleimide-sensitive
factor (NSF) attachment protein receptor (SNARE) proteins, that may
use ubiquitination to regulate their trafficking function. Furthermore, we
quantitatively measure changes in ubiquitome levels following expres-
sion of the Pib1-DUb antiligase, to demonstrate the potential this com-
bination of approaches has toward deciphering the function of Ub-
ligases.
2 | RESULTS AND DISCUSSION
2.1 | A systematic library of ligase-DUb fusion
proteins
A chimera of Rsp5 and the deubiquitinting enzyme (DUb) UL36 from
the Herpes simplex virus I creates a dominant negative “anti-ligase”
fusion protein that specifically deubiquitinates Rsp5 substrates.24 We
FIGURE 3 Legend on next page.
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hypothesized this strategy could be applied to make an array of tools
to probe the molecular functions of other E3 ligases (Figure 1A). We
created a comprehensive E3 ligase-DUb plasmid library encoding
“anti-ligases”, corresponding to each yeast open reading frame (ORF)
predicted to encode an E3 ligase.9 Each putative ligase was fused in
frame to the UL36 catalytic domain and the Hemagglutinin (HA) epi-
tope. The chimeras were housed in a URA3-containing plasmid and
their expression placed under the inducible control of the CUP1 pro-
moter, allowing production in media supplemented with copper
(Figure S1A, Supporting Information). Transforming the ligase-DUb
expressing plasmids into yeast and immunoblotting extracts from
2 independent transformants with anti-HA confirmed expression and
the correct predicted molecular weight for the set of ligase-DUb plas-
mids (Figure 1B). We found a few instances in which Ura+ transfor-
mants did not express the HA-tagged ligase-DUb, emphasizing the
importance of confirming expression of the ligase-DUb in future
experiments. For a small subset of ligases, we could not recover plas-
mids that expressed detectable levels of a modified DUb-HA fusion
counterpart (Figure S1B,C).
To test whether particular DUb fusions elicit specific effects, we
tested the ability of the ligase-DUbs to perturb cellular growth on
their own or in combination with environmental stresses (Figure 2).
Yeast transformants carrying each of the ligase-DUb plasmids grew
comparably well in media containing low levels of copper (SD-Cu),
where expression from the CUP1 promoter was limited, or in media
containing a copper chelator (SD + bathocupriosulfonic acid [BCSA])
to decrease CUP1-dependent expression even further. One exception
was a modest reduction of growth in SD-Cu of cells expressing
Hex3-DUb. This growth phenotype was not observed in SD-BCSA,
but was dramatically exacerbated in media containing high 50 μM
CuCl2 to activate full production from the CUP1 promoter
(Figure 2A). Copper-induced expression of Rsp5-DUb resulted in a
severe growth defect, whereas expression of Rtc1-DUb and Snt2-
DUb caused obvious yet more modest growth defects. Similarly, cells
expressing some ligase-DUbs had defects when exposed to increased
temperature (37!C), alternate carbon sources, (oleate and/or ethanol/
glycerol) or both (ethanol glycerol at 37!C). We also found that mito-
chondrial morphology was aberrant in cells expressing DUb fusions
of the F-box proteins Mfb1 and Mdm30, which have been previously
implicated in regulating mitochondrial dynamics, with their loss caus-
ing mitochondria to fragment and aggregate.25 Both Mfb1-DUb or
Mdm30-DUb altered the ribbon morphology observed in wild-type
cells to one that was fragmented (Figure 2B).
To directly demonstrate that a particular substrate could be
targeted by its cognate ligase-DUb, we focused on 2 Rsp5 sub-
strates, Sna3 and Cos5, that receive a ubiquitination signal that
directs their sorting into the vacuolar lumen.23,26,27 Both Sna3 and
Cos5 bind Rsp5 directly (Figure 3A) and their mono- and di-
ubiquitinated species can be detected as slower migrating species
by Sodium dodecyl sulfate - Polyacrylamide gel electrophoresis
(SDS-PAGE) and immunoblotting. As previously documented,
expression of Rsp5-DUb disrupts the sorting of both Sna3 and
Cos5,23,27 demonstrated by Green fluorescent protein (GFP) tagged
versions localizing to endosomal structures instead of the vacuole
lumen (Figure 3B). As expected, blocking the vacuolar degradation
of Sna3 and Cos5 results in a large increase in steady state protein
levels (Figure 3C). To compare the levels of ubiquitinated Sna3 and
Cos5, we performed analysis in vps36 cells that are incapable of
sorting these substrates into the vacuole for degradation. Because
vacuolar degradation was blocked, levels of Sna3-HA and Cos5-HA
in vps36 cells following expression of Rsp5-DUb were far more
similar and allowed a clear comparison of the ubiquitinated species
(Figure 3D). From this experiment, we found that the levels of ubi-
quitinated Sna3 and Cos5 were markedly depleted upon expression
of the Rsp5-DUb antiligase (Figure 3E).
Collectively, these experiments show that each ligase-DUb fusion
can be inducibly expressed by the addition of copper to the media
and that they can elicit specific and potent phenotypes.
2.2 | Ligase-DUbs block degradation of substrates
We next tested whether other ligase-DUb fusions could specifically
stabilize substrates, as we found for Rsp5-DUb24 (Figure 3). The
ligase Hrd1 has a well-established role in ubiquitinating substrates for
the ER-associated degradation (ERAD) pathway.28,29 A model mis-
folded ERAD substrate is CPY*, a mutant form of CPY expressed by
the prc1-1 allele.30 CPY* is ubiquitinated by Hrd1 at the ER and
degraded by the proteasome.6 We found inducing the expression of
FIGURE 3 Deubiquitination of Rsp5 substrates with Rsp5-DUb antiligase. A, Schematic showing interactions of Rsp5 with substrates, Sna3 and
Cos5. The PPxY/PY motif of Sna3 is required for interaction with the WW domains, which contains two conserved Tryptophans (W), of Rsp5
(upper). The N-terminal cytosolic portion of Cos5 is sufficient to confer a ubiqutination signal for vacuolar degradation. The C-terminal cytosolic
portion of Cos5 can bind directly to Rsp5. B, Wild-type cells expressing either Sna3-GFP or Cos5-GFP were grown to mid-log phase before
addition of 50 μM CuCl2 to induce expression of Rsp5-DUb from the CUP1 promoter. Cells were grown for a further 3 hours before harvesting
and preparation for fluorescence microscopy. Control cells co-transformed with an empty vector were included (left) and 5 μm scale bars are
indicated. C, Wild-type cells expressing Sna3-HA or Cos5-HA were grown to mid-log phase before induction of Rsp5-DUb for 3 hours. Cells
were then harvested, lysed and prepared for immunoblot analysis with anti-HA and anti-CPY antibodies. Three transformants for each condition
were analyzed. D, HA-tagged Rsp5 substrates (Sna3 and Cos5) were expressed in vps36 cells co-expressing Rsp5-DUb (+), or co-transformed
with a vector control (−), before equivalent volumes were harvested and prepared for immunoblot analysis. Unmodified Sna3-HA (left) and
Cos5-HA (right) are detected in addition to the mono-ubiquitinated (*) and di-ubiquitinated (**) species of each substrate. Contrast of
ubiquitnated species (red box) was adjusted to allow densitometry analysis. E, The intensity of each unmodified, mono-ubiquitinated (Ub) and di-
ubiquitinated (Ub ~ Ub) band for both Sna3-HA and Cos5-HA from (D) was measured using Fiji biological-image analysis software and used to
ratio the level of ubiquitination/unmodified for each sample. The levels of mono- and di-Ub bands following expression of Rsp5-DUb are
compared to vector control (100%; dotted line) and depicted as a histogram. Error bars indicate the standard deviation from 2 experiments. CPY,
carboxypeptidase Y; DUb, deubiquitinating enzyme
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FIGURE 4 Substrate specific ligase reversal. A, Mutant prc1-1 (CPY*) cells expressing labeled ligase-DUb fusions were grown to mid-log phase
before equivalent cells were harvested from each culture. Lysates were generated by treatment with 0.2 M NaOH, resuspension in Laemmli
sample buffer containing 8 M urea, followed by Sodium dodecyl sulfate - Polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot
analysis using antibodies that recognize CPY*, PGK and Dpm1. Different exposures of α-HA immunoblots have been separated by spaces/
dotted lines. The steady state levels of CPY* were quantified by densitometry using Fiji software and normalized against loading control (right).
Replicate number (n=) is indicated and the SD shown with error bars. B, prc1-1 cells transformed with vector, Hrd1-DUb and Roy1-DUb were
grown to mid-log phase, treated with 200 μg/mL cycloheximide before samples were harvested for immunoblotting at 0, 30 and 60-minute
time-points. Resolved lysates were probed with antibodies raised against HA, CPY* and PGK. The levels of CPY* were compared to the PGK
loading control using densitometry and used to plot the degradation kinetics of CPY* over time, depicted in line graph (right). The SD from
3 experiments is shown with error bars. C, BY4741 cells stably expressing Cln2-TAP and expressing labeled ligase-DUb fusions from a plasmid
were grown to mid-log phase an prepared for immunoblot analysis with anti-HA, anti-TAP, anti-CPY and anti-Rsp5 antibodies. Non-specific bands
are labeled with an asterisk (*). Cln2-TAP levels were quantified as described in (A). CPY, carboxypeptidase Y; DUb, deubiquitinating enzyme
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Hrd1-DUb caused a dramatic accumulation of CPY* (Figure 4A). This
effect was specific to CPY* because no accumulation was observed
for Pgk1 or the ER resident Dpm1. In addition, expressing various
other DUb fusions had no significant impact on the levels of CPY*.
We did note that addition of copper alone appears to decrease the
levels of CPY*, although we did not pursue an explanation for this
effect. Despite this effect of copper alone, it was clear that CPY* was
greatly stabilized by Hrd1-DUb expression but not other ligase-DUbs
(Figure S2A). Expression of Hrd1-DUb also specifically blocked degra-
dation of CPY* following a cycloheximide chase period (Figure 4B), a
commonly used method to assess ERAD substrate degradation.31
The Grr1 ligase is known to target the cell cycle regulators Cln1
and Cln2, which are rapidly degraded by the proteasome.32 Grr1 is
one of many F-box proteins, which are the substrate binding subunit
of a larger Skp1-Cullin-F-box architecture that forms an active Ub-
ligase complex. We found that the levels of Cln1 and Cln2 are
increased in both haploid and diploid cells expressing Grr1-DUb,
whereas expression of other ligase-DUbs had little effect (Figures 4C
and S2B,C). In contrast, DUb fusion to another F-box protein, Cdc4,
which targets Sic1 for degradation,33,34 increased the levels of Sic1
but not Cln1.
2.3 | Ligases involved in post-Golgi membrane
trafficking
We next used the library to screen for ligases that might be involved
in endosomal membrane trafficking. We used 2 assays: first was a
growth assay in media containing low tryptophan (Trp), which reveals
a growth benefit to cells that can stabilize the high affinity trypto-
phan permease Tat2 at the cell surface. The second assay was secre-
tion of the soluble vacuolar protease CPY, which serves as a general
measure of proper sorting for many steps within the post-Golgi/
endosomal pathway.35
For the Tat2 activity assay, we have previously documented that
accelerated Multivesicular body (MVB) sorting of Tat2 results in a
growth defect in low Trp,27 and reasoned that any ligases that exert
influence on the ubiquitination status of Tat2 would result in a
growth advantage (Figure 5A). Limiting Tryptophan resulted in a
growth defect in cells expressing some ligase-DUb fusions but not
others, emphasizing that different ligase-DUbs produce specific
effects, further supporting data in Figure 2. The 3 ligase-DUbs that
conferred the strongest growth advantage were those built with
Pib1, Tul1 and Rsp5. Replicates of these DUb fusions show obvious
FIGURE 5 Screen for ligases involved in
Multivesicular body (MVB) sorting using
Tat2 as a reporter. A, Schematic diagram
showing how the cell surface localization of
the high affinity tryptophan permease
(Tat2) can be used to increase yeast cell
survival when grown in restricted
tryptophan conditions. B, Growth assays
were carried out in SC-Ura media
containing 50 μM copper to induce
expression of the DUb fusion library. An
initial screen of all ligases in replete Trp
(40 mg/L) and low Trp (2.5 mg/L) media
was carried out. Twenty ligase-DUb fusions
that showed potentially increased viability
in low Trp were subjected to a further
series of assays on plates containing 40, 2,
1.5, 1 and 0.5 mg/L Trp to establish
growth enhancement more accurately. The
growth advantage in low Trp was compared
with growth in replete conditions and
scored on an arbitrary scale between −6
(for greatest growth defect) and +4
(greatest growth enhancement) and
0 indicating no change in growth compared
with a vector control from the same plate.
Ligase-DUb fusions that confer a significant
growth advantage (red dotted line) are
labeled. C, Representative experiments
showing the 3 ligase-DUb fusions (Rsp5,
Pib1 and Tul1) exhibiting a concentration
dependent growth advantage in limited Trp.
DUb, deubiquitinating enzyme
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growth enhancement when compared with vector alone (Figure 5B,
C). The Rsp5-DUb fusion grows very poorly compared with vector
control on minimal media containing copper, but this difference was
almost entirely lost when cells are grown on low Trp media
(Figure 5C), showing that despite the general growth defect in com-
plete media, Rsp5-DUb allows cells to grow better in low Trp. The
effect of Rsp5-DUb on growth in limited Trp is consistent with the
known role of Rsp5 in targeting Tat2 for ubiquitination and Ub-
dependent degradation in the vacuole.36 The finding that Tul1-DUb
gives enhanced growth in low Trp media also indicates reduced deg-
radation of Tat2. This effect is consistent with previous studies impli-
cating Tul1 in the ubiquitination and degradation of a variety of
endosomal membrane proteins, such as mutant SNARE proteins and
endogenous proteins, such as Phm5 and Cps1, which are well charac-
terized cargoes that follow a Ub and ESCRT-dependent route to the
vacuole.37–39 The Pib1 ligase has previously localized to endosomal
compartments via its PtdIns-3P binding Fab1, YOTB, Vac1 and EEA1
(FYVE) domain,40 consistent with the idea that Pib1-DUb perturbs
Ub-dependent sorting of Tat2 through the MVB pathway to the vac-
uole. As confirmation that Tul1-DUb and Pib1-DUb have effects on
ubiquitinated membrane protein cargoes, we found that their expres-
sion sensitized cells to canavanine, a toxic arginine analog that is
transported through the Can1 permease (Figure 6A). Can1 is subject
to ubiquitination and endocytosis to the vacuole; preventing ubiquiti-
nation stabilizes Can1 at the cell surface, which therefore allows for
better canavanine transport and higher toxicity. Thus, these data are
consistent with an effect of Tul1-DUb and Pib1-DUb to stabilize
Can1 at the cell surface. We also found that mutating the active site
cysteine with the DUb catalytic domain of Pib1 abolished this effect
showing that canavanine-sensitivity requires active deubiquitination
FIGURE 6 Validation of ligases involved in the MVB sorting pathway. A, Wild-type cells transformed with vector control, Pib1-DUb or Tul1-
DUb were grown to mid-log phase before equivalent volumes harvested and spotted out in serial dilution (1:9) on SD-Ura-Arg media containing
50 μM copper chloride and varying concentrations of canavanine (upper). Experiments were repeated on media containing Arginine (middle),
including a control set in which a catalytically dead version of Pib1-dub* was expressed (lower). B, Cells transformed with either Ste3-GFP or
Ste3-GFP-Ub alongside active and inactive versions of Pib1-DUb and Tul1-DUb were grown to mid-log phase before copper addition to induce
expression of DUb-fusions. Cells were harvested and prepared for fluorescence microscopy after 2 hours. The 5 μm scale bars are indicated.
DUb, deubiquitinating enzyme
472 MACDONALD ET AL.
FIGURE 7 Screen for ligases involved in vacuolar sorting of soluble hydrolases. A, Schematic diagram of CPY trafficking, where newly
synthesized CPY traffics to the Golgi, where it is modified to a p2-CPY precursor form (black dots) before trafficking to late endosomes,
packaging into luminal vesicles at the MVB and sorting to the vacuole where it is processed to the final mature mCPY form (black circular
sector). This sorting is defective in vacuolar protein sorting pathway (vps) mutants and p2-CPY is instead secreted from the cell. B, SEY6210
cells expressing both clones (Figure 1B) of the DUb-fusion library were grown in the presence of copper and overlaid with a nitrocellulose
membrane. Levels of secreted CPY were assessed by immunobloting the membranes with anti-CPY antibodies. All experiments contained vector
controls of wild-type cells, as a negative control, and vps4Δ cells, which secrete >40% CPY, as a positive control. C, Overlay experiments
showing that pib1Δ and tul1Δ null cells do not secrete CPY, unlike vps4Δ and vps8Δ cells. However, expression of dominant antiligase versions
of Pib1, Tul1 and Vps8 all secrete CPY, an effect that relies on the catalytic activity of the DUb fusion (dub* versions express a catalytically
dead Cys > Ser mutant version). D, Expression of DUb fusions, and catalytically dead (dub*) versions, was assessed by immunoblot analysis of
lysates generated from cells incubated in media containing copper for 2 hours. E, CPY secretion of wild-type, pib1Δ and tul1Δ cells transformed
with an empty vector (left) or Rsp5-DUb (right) was assessed by immunoblotting the levels of CPY secreted onto an overlaid membrane during
an overnight incubation. CPY, carboxypeptidase Y; DUb, deubiquitinating enzyme
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by Pib1-DUb. We also found that both Tul1-DUb and Pib1-DUb
interrupted the normal delivery of Ste3-GFP along the MVB pathway
into the lumen of the vacuole (Figure 6B), again consistent with the
idea that each of these ligase-DUbs can target endosomal membrane
proteins.
We next evaluated the ligase-DUbs for effects on the sorting of
CPY to the vacuole (Figure 7A,B). Despite extensive screening for
proteins involved in this pathway,35,41 an E3 ligase has not yet been
implicated in the process. CPY secretion was measured using an
immunoblot assay to detect secreted CPY from colonies over-layed
with nitrocellulose filters. Mutant vps4 cells that secrete approxi-
mately 40% of their CPY,35 were used as a comparative control. This
assay revealed that expressing Pib1-DUb and Tul1-DUb caused mis-
sorting of CPY. The CPY secretion defect upon expression of Pib1-
DUb is unlikely due simply to the ability of Pib1 to associate with
endosomes through its FYVE domain, as fusion of a DUb to ESCRT-0
FIGURE 8 Legend on next page.
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(a complex of Hse1 and Vps27, the latter containing a FYVE domain)
efficiently deubiquitinates Vps27, inhibits ESCRT recruitment and
sorting of ubiquitinated MVB cargoes, but does not result in a CPY
secretion defect.24,42,43
Our assay also showed that CPY was missorted upon expression
of DUb-fused Vps8, a CORVET specific subunit that plays an essen-
tial role in the vesicle biogenesis process, alongside Vps3 and the
core Class C subunits, which are also the main components of the
HOPS complex that drives homotypic fusion of the vacuolar mem-
brane.44 Yet DUb fusions with other HOPS/CORVET components
that also have the RING domain signatures of Ub-ligases (Vps11 and
Vps18) did not cause CPY secretion (Figure S3). This suggests that
Vps8 controls a Ub-dependent function when it is not in complex
with other CORVET subunits.
In more general terms, our experiments uncover the existence of
1 or more Ub-dependent trafficking steps required for proper Tat2
trafficking and CPY sorting. Moreover, they implicate Pib1, Tul1 and
Vps8 as ligases that contribute to this process. This is inferred from
the dominant-negative effect that Pib1-DUb, Tul1-DUb and Vps8-
DUb have on endosomal sorting. The idea that this is due to pertur-
bation of a ubiquitination event is supported by the observation that
expressing Pib1, Tul1 or Vps8 fused to a catalytically dead deubiquiti-
nase domain has no effect on CPY secretion (Figure 7C,D).
An important aspect of interpreting results from the ligase-DUb
expression experiments is the model that these fusions work as
dominant-negative alleles, perturbing the ubiquitination events cata-
lyzed by endogenous ligases. Thus, even if a substrate is targeted by
multiple ligases, only a single ligase-DUb is theoretically required to
reverse those events. For Pib1 and Tul1, we confirmed earlier studies
showing that single deletion of either PIB1 or TUL1 did not cause a
Vps- (CPY secretion) phenotype (Figure 7E). To test whether redun-
dancy amongst Pib1, Tul1, Vps8 and perhaps other Ub-ligases was
responsible for the Ub-dependent effects of CPY sorting, we tested a
series of combined mutants. A pib1Δ tul1Δ double mutant also did
not secrete CPY, however, we could not recover double mutant cells
that were capable of respiration on glycerol/ethanol plates, suggest-
ing some type of genetic interaction (Figure S4A). As loss of Vps8
itself causes CPY secretion, combining vps8Δ with other mutations
would not have been informative. We did make alleles in which the
C-terminal RING finger was deleted or altered in hopes of retaining
the bulk of Vps8 function whilst removing its Ub-specific function.
However, these vps8 alleles did not complement CPY sorting
(Figure S4B). A CPY secretion phenotype for pib1Δ mutants was
observed when the function of Rsp5 was also perturbed, by expres-
sing Rsp5-DUb (Figure 7E). Although neither a pib1Δ mutant nor
expression of Rsp5-DUb alone caused CPY secretion (Figure S3), the
combination did result in a low level of secretion, suggesting interplay
between the endosomal ligases (Figure 7E).
Our observations using Pib1, Tul1 and Vps8 DUb fusions high-
light an important caveat with interpreting results of using the ligase-
DUb panel in general. On the one hand, the effect of a ligase-DUb
could be that it directly antagonizes the effect of its endogenous
wild-type ligase counterpart. This effect is consistent with what we
observe for Hrd1-DUb, Grr1-DUb, Mfb1-DUb and Rsp5-DUb and in
line with the concept of a dominant-negative mutant. Alternatively,
expression of a ligase-DUb could perturb the ubiquitination of a pro-
tein that is not a native substrate of the wild-type ligase. Even with
this caveat, the ease of using the panel of ligase-DUbs to either fol-
low the levels of a particular substrate (eg, Cln2 or CPY*) or a biologi-
cal function (eg, Mitochondrial morphology or CPY sorting) make it
an appealing way to identify candidate ligases that may play a role in
a particular Ub-dependent process. Thus, these tools could provide
new leads that can be followed up with more detailed analyses.
In the case of deciphering the role of Pib1, Tul1 or Vps8 in Ub-
dependent steps that are required for proper sorting of vacuolar
hydrolases, one way forward would be to determine how the reper-
toire of ubiquitinated proteins is altered by ligase-DUbs in order to
find their candidate substrates, which in turn could shed light on the
FIGURE 8 Optimization of ubiquitome preparations in yeast. A, Protein extracts were prepared by incubating harvested yeast cells in urea
buffer (50 mM Tris pH 6.8, 10% glycerol, 8 M urea and bromophenol blue) either solely (−), with glass beads and vortexing (GB), or by addition
of 3% SDS to buffer (SDS). Manipulations were also compared following a 3-minute incubation in 0.2 N NaOH. All lysates were analysed by
SDS-PAGE and Coomassie staining. B, Cells expressing His-HA-tagged ubiquitin were used to prepare lysates using the alkali and SDS method.
Lysates were generated immediately (!) as in (B), or samples were treated with NaOH for 2 minutes (+) and an untreated control (−) prior to
incubation in 50 mM NaN3 for 30 minutes at room temperature. Lysates were then immunoblotted using anti-His tag and anti-PGK
antibodies. C, Protein extraction methods were compared from 10, 100 and 1000 mL cultures, using anti-PGK, anti-CPY and anti-Dpm1
antibodies. The original lysates (Prep A) were stored in −20!C freezer and then analyzed alongside fresh lysates generated from cultures of the
same volume (Prep B). An equivalent number of cells amongst the lysates generated from 10, 100 or 1000 mL cultures were analyzed. D,
Whole-cell yeast lysates were generated using lysis buffer containing 3% SDS. SDS was then removed using centrifugal filtration devices (left) or
by dialyzing against lysis buffer lacking SDS (right). Different protein amounts from each sample were analyzed by silver stain before (−) and
after (+) detergent removal. E, Left, wild-type cells expressing different His-tagged ubiquitin constructs were analyzed by silver stain and
immunoblot using anti-His antibodies. Different linker regions (none, 2, 4, 6 and 8 amino acids) between the His6-tag and Ubiquitin were
compared. Right, cells expressing His-(no linker)-Ub and His-(8 amino acid linker: ALINQERA)-Ub cells were grown to mid-log phase and lysates
were generated to compare original material. These lysates were then used to perform Ni2+-Nitrilotriacetic acid (NTA) affinity purifications, and
the yield of protein for each transformant analyzed by silver staining and anti-His immunobloting. F, Schematic diagram of 2-step affinity
purification of His-tagged ubiquitin. G, His-Ub conjugates were affinity purified from parental control yeast cells (lacking His-Ub) and cells
expressing His-ALINQERA-Ub expressed from the CUP1 promoter. An additional sample was prepared from His-ALINQERA-Ub expressing cells
that were treated with 20 mM MG-132 for 45 minutes prior to harvesting and extraction. A sample of the initial lysate was analyzed by silver
stain and immunoblotting using anti-His antibodies. Purifications were performed using a 1-step protocol (see methods), that involved binding to
a nickel column and elution using low pH buffer, or a 2-step protocol that involved neutralizing the initial elution, rebinding to Ni-NTA and
eluting with imidazole. Immunoblot analysis of the 2-step protocol was also performed using anti-Ub antibodies
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FIGURE 9 Identification of ubiquitinated factors implicated in membrane trafficking. A, Scheme for integrating the TEF1*-6xHis-ALINQERA-Ub
cassette in place of the endogenous UBI4 gene. B, Susceptibility of pdr5Δ ubi4Δ::TEF1*-6xHis-ALINQERA-Ub to the proteasome inhibitor
MG132 and the protein translation inhibitor cycloheximide. Cells were grown in liquid culture in the presence of the indicated concentrations of
MG132. Growth was monitored by OD600 and plotted relative to that of wild-type cells grown in the absence of drug (upper). Cells were serially
diluted and plated onto SD media or SD media containing 0.2 μg/mL cycloheximide (lower). C, Representative His-ALINQERA-Ub purification,
with samples removed at each stage and prepared for analysis by silver stain and anti-His immunoblot. D, Affinity Ni2+-NTA purification of
lysates generated from ubi4Δ pdr5Δ hbt1-CΔ yeast cells not expressing His-tagged proteins. Contaminant proteins that bind strongly to the
nickel column were eluted, visualized by silver stain and then identified by mass spectrometry (listed in table below). E, Purifications of lysates
generated from ubi4Δ pdr5Δ and ubi4Δ pdr5Δ hbt1-CΔ strains. The insert shows a zoomed in image of the purified Hbt1 band. F, Yeast cells
expressing His-ALINQERA-Ub were treated with MG-132, with a control untreated sample, before lysates were generated and samples were
prepared for tandem MS/MS analysis. Triplicate experiments were performed for each condition. The number of unique peptides identified for
the initial directed MS run (dark grey) or following recursive analyses (light grey) is depicted. G, Proteins identified from analysis described in
(F) were collated and differences following MG-132 treatment displayed as a Venn diagram (upper) and the change in protein levels following
drug treatment shown (lower). Less than a 1.5-fold increase/decrease upon drug treatment was considered unaltered (grey).
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substrates of their endogenous wild-type ligase counterpart. Several
protocols have been described for isolating and quantifying ubiquiti-
nated proteins by mass-spectrometry. However, we found that these
had problems in maximizing yield and purity of the ubiquitome.
Therefore, we set out to optimize procedures for purifying pools of
ubiquitinated proteins so that they could be easily compared to dis-
cover ligase-substrate relationships.
2.4 | A proteomic workflow for isolating and
analyzing the ubiquitome
Optimizing the isolation of ubiquitinated proteins involved 3 main
considerations: comprehensive cell lysis, a tight affinity tag for ubiqui-
tinated proteins and a simple yet very selective affinity purification
scheme for enrichment. These pools of ubiqutinated proteins would
then be subjected to tryptic digestion and Liquid chromatography–
mass spectrometry (LC-MS/MS). We felt a highly purified fraction
was critical to the overall strategy since designating whether a pro-
tein is ubiquitinated, and then quantifying its abundance, could rely
on measuring any peptide of that protein rather than only peptides
containing remnants of lysine ubiquitination (a di-Glycine “stump”
that remains attached to the ubiquitinated lysine after trypsin diges-
tion). This strategy would cast a wider net for identifying ubiquiti-
nated proteins that might not contain enough detectable di-glycine
peptides for quantitation, or that may have a plethora of ubiquitina-
tion sites that do not accurately reflect what proportion of a protein
pool is ubiquitinated.
For extraction, the treatment of cells with alkali (0.2 N sodium
hydroxide) prior to SDS lysis45 was the most efficient extraction
method that also significantly reduced the deubiquitination of modi-
fied species when cells or non-denatured lysates are incubated with-
out energy renewal (Figure 8A,B). As originally described, NaOH/SDS
prepared lysates are typically performed on small volumes of yeast.
Because large quantities of lysates are required for downstream pro-
teomic analysis, we confirmed that scaling up this procedure did not
adversely affect reproducibility of extraction, as shown by immuno-
blotting the same amount amounts of lysates generated from 10 mL,
100 mL and 1000 mL cultures for marker proteins localized to the
ER, cytosol and vacuole (Figure 8C). It was then crucial to remove
SDS from samples so that they could be analyzed by LC-MS/MS. Pre-
vious methods describe a urea buffer exchange protocol using an
ultrafiltration device.46 Comparing this buffer exchange method with
simple dialysis against urea buffer revealed dialysis removed SDS as
quickly as centrifugal exchange, but with much less loss in overall
protein levels (Figure 8D). This is an important consideration, as over
50% of sample was not recovered following buffer exchange. Consid-
ering, proteins of a certain size and/or hydrophobicity may be dispro-
portionately lost during the removal of SDS, the landscape of the
proteome could be significantly altered by not using dialysis, and it is
therefore preferable to dialyze against large volumes of denaturing
buffer. Even if proteins are depleted equally, this loss presents an
unwieldy technical workflow to compensate.
We next focused on expression of 6xhistidine (His)-tagged Ub
for capturing the ubiquitome. Procedures for isolating ubiquitinated
proteins rely on expressing a 6xHis-tagged Ub in cells followed by
affinity isolation of the 6xHis tag on Ni-NTA attached to sepharose.47
Ni-NTA purification of 6xHis-ubiqutuinated proteins is advantageous
because it can be done under denaturing conditions, specifically 8 M
urea, which is the buffer into which our protein lysates are dialyzed.
During our initial optimization of different commercially available Ub
and His-tag antibodies it became apparent that anti-HisTag antibo-
dies could not recognize 6xHis-Ub efficiently. Inserting a linker region
of at least 6 or 8 amino acids was necessary to expose the epitope
for immunodetection. Importantly, including this spacer also led to a
considerable increase in the yield of purified ubiquitome, presumably
by making the tag more accessible to the immobilized Ni-NTA
(Figure 8E).
Using a single affinity isolation step to purify proteins on Ni-NTA
sepharose was insufficient for eliminating non-specific proteins. This
problem is exemplified by purifications from His-Ub expressing cells
being indistinguishable from control cells lacking His-Ub, when
assessed by silver staining of eluates. However, western blotting
showed cells expressing His-Ub to be greatly enriched in ubiquitome.
TABLE 1 Ni2+-NTA contaminants from yeast cell lysate
Band Protein
Molecular weight
(MW) (kDa)
Unique
peptides Coverage
Abundance
(Mol./cell)
Histidine
content Possible native His tag
1 Rpl28 17 15 74% N/A 6.7% Not obvious
2 Nma1 46 29 39% 5127 5.2% K60-HHHHHHH-S68
3 Sro9 48 101 66% 8424 3.9% P173-HHRNHHHSHHH-N185
4 Snf1 72 45 27% 589 4.9% S17-HHHHHHHHHHHHH-G31
5 Ybr238c 84 33 36% 2083 5.1% N98-HHNNNRNHHH-N109
6 Hrk1 86 51 32% 299 6.2% F10-HGHHNDHHH-D20 &
Q697-HHHHQH-Q654
7 102 30 26%
8 Ubp3 114 25 24% 2205 3.2% A249-HHHTKSH-S256
Not
shown
Hbt1 — — — N/A 4.5% K966-HHHNHHRH-S975
Matrix-assisted laser desorption/ionization - Time of flight (MALDI-TOF) identification of protein bands from Figure 9C, which were generated following
affinity purification of parental strain ubi4Δ pdr5Δ hbt1-CΔ (not expressing His-tagged ubiquitin) on Ni2+-NTA agarose resin. Relevant identification infor-
mation, abundance and histidine content is also included, which probably explain protein affinity to resin. Details of the Hbt1 are also included, although
the hbt1-CΔ truncation successfully removes this contaminant from purifications and the protein was not detected on silver-stained gel processed for
MALDI-TOF analysis.
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We found that a 2-step purification almost entirely removed this
non-specific background. Two-step purification of His-Ub was rela-
tively simple, as the initial elution was performed at low pH, followed
by neutralization, binding to a smaller bed volume, washing and imid-
azole elution, resulting in a much higher level of purification
(Figure 8F,G). Indeed, the only remaining contaminants were identi-
fied as endogenous proteins that contain motifs mimicking His-tags,
such as Snf1 that has 13 contiguous histidine residues in its N-
terminal region and Hbt1 that contains multiple histidines within its
C-terminal region (Figure 9C; Table 1).
We then built a yeast strain that expressed 6xHis-tagged Ub with
an inserted 8 amino acid linker (6xHis-ALINQERA-Ub). Expression
was from an engineered form of the TEF1 promoter that yields a
moderate level of expression.48 Rather than replace all endogenous
Ub genes with expression of 6xHis-Ub from a variable copy 2 μ plas-
mid, as has been done is some previous studies, we integrated our
expression construct in cells with either all 4 of their Ub-encoding
genes intact, or integrating our construct at the UBI4 locus to replace
one of the main Ub-producing genes. We found that the loss of UBI4
increased the overall yield of ubiquitinated proteins 5-fold
(Figure 9A). We also deleted the PDR5 gene, which encodes a broad-
specificity efflux pump. This mutation sensitizes cells to drugs such as
cycloheximide and increases the efficacy of the proteasomal inhibitor
MG-132, which could be used in downstream experiments to accu-
mulate proteasomal substrates (Figure 9B).
Of the endogenous protein contaminants following 2-step purifi-
cation (Figure 9C), initial mass-spectrometry analysis of the ubiqui-
tome fraction from these cells revealed that a major component was
the contaminant protein Hbt1. This presented a significant problem
because its abundance was so high that it interfered with the detec-
tion of other proteins within the sample. Hbt1 is a approximately
114 kDa protein that contains a C-terminal region with many tandem
Histidine residues. Its ability to bind directly to Ni-NTA explains how
it was found originally in studies looking for binding partners for His-
tagged Hub1.49 It was also the only protein identified in all 4 experi-
mental replicates in a recent mass spectrometry study isolating His-
Ub conjugates.50 We sought to eliminate this contaminant to allow
for a broader identification of peptides by mass spectrometry.
Although the function of Hbt1 is not clear, we found that deletion of
HBT1 in the ubi4Δ pdr5Δ cells caused a growth defect (data not
shown). As an alternative, we truncated the endogenous HBT1 ORF,
removing the C-terminal portion containing the native poly-histidine
tag (Table 1) while retaining the majority (residues 1-996) of the
protein-coding region. This manipulation has no effect on growth.
Importantly, this eliminated the ability of Hbt1 to bind to Ni-NTA and
removed it as a confounding contaminant in our ubiquitome samples
(Figure 9D). Combining these approaches led to our final optimized
purification protocol for affinity purifying the ubiquitome (Figure 9E).
To optimize the identification of ubiquitinated proteins by mass
spectrometry, we found that recursive analyses performed on a modi-
fied exclusion list increased both the total number of proteins identi-
fied and the coverage of identified proteins (Figure 9F). This was
done by subjecting a single sample to multiple rounds of LC-MS/MS
using an Agilent 6520 Q-TOF instrument, and placing all of the suc-
cessfully identified peptides on an exclusion list used to direct MS
analysis in each subsequent round, as previously described.51 This
workflow was then used to perform 6 independent ubiquitome purifi-
cations, 3 under normal conditions and 3 in the presence of MG-132
to inhibit proteasomal degradation (Figure 9G), an approach that has
been previously validated by mass spectrometry.52 We identified
almost 3000 proteins from these analyses. The relative levels of many
of these were altered upon inhibition of the proteasome. Although
not specifically targeted, this analysis also identified specific lysine
residues containing a di-Gly stub, indicating some specific ubiquitina-
tion sites, some of which are novel; showing that the method
enhancements described here will be useful for more detailed studies
later. This analysis also highlighted several proteins that function in
the endocytic pathway and could be targets of the Vps8-DUb, Pib1-
DUb and/or Tul1-DUb proteins that cause endosomal sorting defects
(Table 2). These include a large number of SNARE proteins (Table 3),
including Snc1, Snc2, Syn8, Vam3, Vti1 and Ykt6, which all function
in membrane fusion events throughout the post-Golgi/endocytic sys-
tem. Other proteins known to function in vacuolar protein sorting
were also identified including components of the ESCRT apparatus as
well as many proteins that help coordinate SNARE-mediated fusion
including Vps8, Vps11, Vps18 and Vps45. Interestingly, Vps10, the
sorting receptor for CPY that cycles between Golgi and endosomal
compartments was identified within the ubiquitome. Alteration of the
function of any of these proteins by ubiquitination could account for
the perturbations we observe in the endocytic pathway upon
TABLE 2 Vps proteins identified by mass spectrometry of yeast
ubiquitome
Protein Distinct peptides Ubiquitination sites
Vps2 4 K51, K52
Vps3 1
Vps8 2 K967
Vps10 2
Vps11 2 K395
Vps13 4 K835
Vps16 3 K25, K639
Vps17 4 K424
Vps18 2
Vps20 2 K42, K46
Vps21 1
Vps22 1
Vps23 1
Vps28 1 K211
Vps30 1
Vps34 1
Vps39 2 K263
Vps45 2 K17, K21, K35, K40
Vps52 1
Vps53 3
Vps54 2
Vps65 1
Vps70 1 K87
Vps72 5 K329, K162, K164
List of vacuolar protein sorting (Vps) proteins and ubiquitnation sites identi-
fied from Figure 9G.
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expression of Pib1-DUb, Tul1-DUb or Vps8-DUb and comparing
changes within the ubiquitome upon their expression using the work-
flow described here should help narrow this candidate list. Intri-
guingly, although Rsp5 does not seem to be directly involved in the
bulk of the ubiquitination required for these membrane trafficking
steps, there was an additive effect of Rsp5-DUb in a pib1Δ back-
ground, suggesting that the function between the endosomal ligases
is partially overlapping (Figure 7E).
The above described assays validate a role Rsp5 in endosomal
ligase activity but suggest that other ligases, in particular Vps8, Pib1
and Tul1, collaborate to ubiquitinate components of the post-Golgi
trafficking machinery, and this is required for upstream trafficking
events, which subsequently converge with an Rsp5-dependent/MVB
pathway. These additional ligases are all known to localize to endo-
somes and some have been reported to be active ligases.38,40,53 The
fact that, for example, pib1Δ cells do not have obvious sorting
defects,40 is in itself suggestive of a redundant role with another
ligase.
2.5 | Alterations of the ubiquitome induced by
Pib1-DUb
As a final exercise, we tested whether the ubiquitome isolation pro-
cedure was reproducible enough to examine the effects of ligase-
DUb expression on the ubiquitome, using the Pib1-DUb antiligase as
an example (Figure 10A). In order to assess changes in the ubiqui-
tome it was tantamount to demonstrate that isolation of the ubiqui-
tome, and subsequent analysis by LC-MS/MS, could yield
reproducible results. This would be key so that changes induced by
ligase-DUb expression could be reliably detected. For this evaluation
we prepared biological replicates from 2 independent experiments
from either control cells transformed with an empty vector or cells
expressing Pib1-DUb (Figure 10B). Samples from cells lacking His-Ub
were also analyzed to confirm efficient and specific purification of
the ubiquitome. Tryptic fragments from ubiquitinated proteins were
isolated before differential di-methyl labeling of amino groups using
“light” and a “heavy” labels, as previously described54 (Figure 10C).
Samples from vector control cells and Pib1-DUb-expressing cells
were mixed at a 1:1 ratio and analyzed by LC-MS/MS using a Thermo
Orbitrap Fusion Lumos instrument, with triplicate injections for each
sample. Unlike the MS procedures described in Figure 9, this analysis
did not employ additional chromatography steps before LC-MS/MS
so as to simplify analysis and comparison of the replicate samples.
Peptides were identified, quantified and compared and are listed in
Table S5. Over all the samples, 587 proteins were identified, how-
ever, for quantitation, only proteins that were found in multiple injec-
tions across both replicates were used for analysis by MaxQuant.55
Also we also found a subset of proteins that were only found in
either the ubiquitomes from control cells or Pib1-DUb expressing
cells (Figure 10D). We found that the levels of individual proteins
within the ubiquitomes from 2 independent experiments were quite
reproducible, for both control and Pib1-DUb samples (Figure 10E).
Interestingly, expression of Pib1-DUb caused a subset of proteins to
be reproducibly reduced from the ubiquitome (Figure 10F). Perhaps
the most relevant finding regarding the utility of the ubiquitome
isolation procedure and its combination with ligase-DUb treatment is
that the levels of a large majority of identified proteins within the
ubiquitomes were unchanged, which supports the overall reproduci-
bility of these techniques and speaks to the specificity of ligase-
DUbs. Second was that this comparative proteomic approach identi-
fied changes in the levels of particular proteins within the ubiquitome
of Pib1-DUb-expressing cells. Proteins that were less abundant in the
ubiquitome of Pib1-DUb expressing cells could be directly deubiquiti-
nated by Pib1-DUb, and thus qualify as potential substrates of
endogenous Pib1. Alternatively, Pib1-DUb could work indirectly to
somehow lower the steady-state levels of those proteins so that less
are available for ubiquitination and recovery in the ubiquitome frac-
tion. Proteins that are depleted from the ubiquitome of Pib1-DUb
expressing cells include 2 Rsp5-adaptor proteins, Ecm21/Art2 and
Art10, supporting the idea that Pib1 and Rsp5 have functional over-
lap or that Pib1 collaborates with Rsp5 to mediate ubiquitination of
substrates of the endocytic/MVB pathway. Also identified were vari-
ous plasma membrane transporters, including Tat1, Sam3, Opt1 and
Fui1.56–59 The idea that Pib1-DUb targets these transporters is con-
sistent with the effects of Pib1-DUb on stabilizing Tat2 and Can1
(Figures 5 and 6) and implies a biological role for endogenous Pib1 in
targeting a wide variety of cell surface proteins for ubiquitination and
degradation in the vacuole. Erg11 (which is required for ergosterol
synthesis60) and Mdm34 (a subunit of the ERMES complex required
for mitochondrial-to-ER contact sites61) are also depleted in the Pib1-
Dub ubiquitome relative to control, suggesting that Pib1 may play a
novel role in lipid homeostasis and interorganelle contact.
3 | SUMMARY
Here, we describe a new tool to study the function of E3 Ub-ligases:
a library expressing ligase-DUb “anti-ligases” that correspond to most
of the known yeast Ub ligases, and which appear to largely function
in a dominant negative manner. This tool complements a variety of
other approaches to study ligase function that together make a more
TABLE 3 SNARE proteins identified by mass spectrometry of yeast
ubiquitome
Protein Distinct peptides Ubiquitination sites
Sec9 2 K610
Sft1 1
Snc1 1
Snc2 1
Spo20 1
Sso1 1
Sso2 1
Sso1/2 2
Syn8 1 K28
Vam3 1 K113
Vti1 2
Ykt6 1
List of soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein
receptor (SNARE) proteins and ubiquitnation sites identified from
Figure 9G.
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FIGURE 10 Modulation of the ubiqutome following Pib1-DUb expression. A, Schematic of ubiquitome purification from pdr5Δ ubi4Δ hbt1-CΔ cells
transformed with vector as a control or Pib1-DUb-expressing cells, across 2 independent experiments. His-tagged Ub (His-Ub) attached to substrates
(grey) facilitates binding to Ni-NTA. His-Ub conjugated to substrates of Pib1 (green) is predicted to be deubiquitinated by Pib1-DUb, thereby diminishing
their recovery on Ni-NTA. B, Ubiquitome purification from ubi4Δ pdr5Δ hbt1-CΔ cells not expressing His-Ub (!), expressing only His-Ub (vector control
samples A and C) and cells co-expressing His-Ub and Pib1-DUb (samples B and D). Samples were analyzed by SDS-PAGE followed by silver staining
(upper) and immunoblotting using anti-His antibodies (lower). C, Experimental scheme for isolation and differential labeling of the ubiquitome from
control and Pib1-DUb-expressing cells. Ubiquitomes were prepared from independent experiments (1 and 2), trypsinized, and subjected to differential di-
methyl labeling (28 Da light label for vector control and 36 Da heavy label for Pib1-DUb samples). Samples were then mixed at a 1:1 ratio and subjected
to LC-MS/MS analysis. D, List of proteins that were detected only in control samples (both A and C) but not detected in ubiquitome purifications
following expression of Pib1-DUb (left) and proteins that were detected only in Pib1-DUb samples (both B and D), right. E, The variability between both
light labeled control experiments (left) and both heavy labeled Pib1-DUb experiments (right) is shown as a ratio of peptide intensity (log2 scale), with pink
squares indicating candidate Pib1 substrates identified in (F). F, The log2 ratio of proteins between the (light) averaged control samples and the (heavy)
averaged Pib1-DUb samples. Proteins reproducibly depleted upon Pib1-DUb expression are highlighted as pink squares. DUb, deubiquitinating enzyme
480 MACDONALD ET AL.
effective approach to deciphering the roles of individual ligases. We
also provide some enhancements and alternatives for isolating ubiqui-
tinated proteins from yeast cells for subsequent identification and
quantitation by mass-spectrometry or other downstream analyses,
thus allowing the coupled use of ligase-DUb perturbation of the ubi-
quitome to find relevant ligase targets. Importantly, the effects of the
ligase-DUb fusion proteins are considerably specific to the pathway
or process in which the native ligase participates. Furthermore, the
ability of ligase-DUbs to stabilize the cognate substrates of their
endogenous counterpart provides a simple and convenient tool to
identify the ligase(s) that mediate degradation of a particular sub-
strate protein of interest. The utility of these ligase-DUbs as a discov-
ery tool is documented by our studies and assays in endosomal
trafficking, where we find that a Ub-dependent process is required
for proper sorting of vacuolar hydrolases, and where we identify spe-
cific ligases and a number of candidate substrates that may effect this
Ub-dependent process. The ligase-DUb library, alongside the opti-
mized reagents and protocols to biochemically assess the yeast ubi-
quitome, is a powerful tool to investigate the molecular mechanisms
of many ubiquitination events that drive various cellular processes.
4 | MATERIALS AND METHODS
4.1 | Reagents
The plasmids, yeast strains and antibodies used in this study are listed
in Tables S1-S3.
4.2 | Cell culture conditions
Standard rich Yeast extract peptone dextrose (YPD) and synesthetic
complete (SC) media lacking appropriate base or amino acids were
used throughout. Expression of plasmids under the control of the
CUP1 promoter was induced by the addition of 50 μM copper chlo-
ride to the media.
4.3 | CPY secretion assay
Yeast cells expressing ligase-DUb fusions were grown to mid-log
phase in minimal media. Equivalent volumes of cells were harvested,
spotted on a minimal media plate containing copper and grown over-
night. Yeast was then replica plated on minimal media plates contain-
ing 50 μM copper chloride, dried and overlaid with a nitrocellulose
membrane and grown at 30!C for 20 hours. Excess yeast were
washed from membrane before immunoblotting with monoclonal
anti-CPY antibodies as described.43
4.4 | Limited tryptophan growth assay
SEY6210 tryptohphan auxotroph (Trp-) cells expressing vector con-
trol or DUb-fusion plasmids were grown to mid-log phase in SC-Ura
media before equivalent volumes harvested, washed in water and
serially diluted (9:1) on plates of replete (40 μg/mL) and restricted
(5 μg/mL and 2.5 μg/mL) Trp levels. This initial screening suggested
approximately 60 ligase DUb fusions exhibited either reduced growth
or had no growth advantage. Approximately 20 fusions were selected
for further analysis, which was performed as described above with
additional platings on very low Trp plates (2 μg/mL, 1.5 μg/mL, 1 μg/
mL, 0.5 μg/mL).
4.5 | Labeling of mitochondria
Yeast cells expressing labeled DUb fusion plasmids were grown to
mid-log phase in SC-Ura media supplemented with either 2% glucose
or 3% ethanol and 3% glycerol as a carbon source. Mitochondira
staining was achieved by addition of 100 nM MitoTracker Red
CMXRos dye to the cultures, which were grown at 30!C for 1 hour
prior to washing with fresh media and imaging by fluorescence
microscopy.
4.6 | Fluorescence microscopy
Yeast cells were grown to mid-log phase prior to resupension in “kill”
buffer containing 100 mM Tris-HCl (pH 8.0), 0.2% (w/v) NaN3 and
NaF, prior to fluorescence microscopy, performed as previously
described.27
4.7 | Immunoblot
Yeast cells harvested at mid-log phase were subjected to alkali treat-
ment (0.2 N NaOH) for 3 minutes followed by resuspension in
50 mM Tris-HCl (pH 6.8), 5% SDS, 10% glycerol and 8 M urea, to
prepare whole cell lysates for SDS-PAGE. Immunoblotting was per-
formed as previously described23 using antibodies listed in Table S3.
4.8 | Ubiquitome purification
A 2 L culture of PLY4272 cells expressing His-ALINQERA-Ub was
grown (per sample) to mid-log phase, harvested, treated for 3 minutes
with 0.2 N NaOH prior to lysates being generated in denaturing buffer
containing 50 mM Tris-HCl pH 8.0, 10% (w/v) glycerol, 5 mM ß-Me
2.5% SDS and 8 M urea. Lysates were then diluted 20- to 30-fold in
binding buffer (denaturing buffer lacking SDS), incubated for 2 hours at
room temperature with 3 mL (50% slurry) Ni2+-NTA agarose and col-
lected in a column. Beads were washed with ×10 with binding buffer
containing 10 mM imidazole and bound proteins eluted using 10 mL
binding buffer at pH 4.5. Lysates were then neutralized (pH = 8.0) by
addition of NaOH and incubated with a 300 μL (50% slurry) Ni2+-NTA
agarose for a further 2 hours. Bound proteins were then eluted in
1500 μL binding buffer containing 350 mM imidazole, dialysed against
buffer lacking imidazole and then prepared for mass spectrometry.
Samples from each stage in the process were removed, resuspended in
Laemmli sample buffer, resolved by SDS-PAGE, and then subjected to
silver staining or immunoblotting for visualization.
4.9 | Mass spectrometry sample preparation
Isolated ubiquitinated proteins were reduced by addition of 10 mM
Dithiothreitol (DTT) powder for 1 hour at 37!C and then alkylated in
55 mM iodoacetamide for 1 hour at room temperature in the dark.
Samples were diluted to 0.75 M urea with 50 mM Tris-HCl pH 8.5
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and proteins digested with 20-μg trypsin (Promega) overnight at
37!C. Each sample was then spiked with a tryptic digest of bovine
serum albumin at a 1:75 molar ratio with protein sample before acidi-
fication and desalting on C18 spin-columns. Samples were then frac-
tionated by strong-cation exchange (SCX) on polysulfoethyl A packed
spin columns. Briefly, desalted samples were dissolved into SCX
buffer A (5 mM KHPO4, 25% acetonitrile [ACN]) and loaded onto
SCX spin-columns. Peptides were eluted from the columns using a
12-step “salt-bump” protocol with buffer containing an increasing
concentration of KCl (10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60 and
120 mM), the gradient was created by mixing buffer A with buffer B
(5 mM KHPO4, 25% ACN and 350 mM KCl). Eluted fractions were
desalted, dried and redissolved in mass spectrometry loading buffer
(1% acetic acid, 1% ACN) and then analyzed by liquid chromatogra-
phy tandem mass spectrometry (LC-MS/MS).
4.10 | Recursive mass spectrometry analysis
Trypsinized samples were analyzed by nano-liquid chromatography-
tandem mass spectrometry using an Agilent 6520 Accurate-Mass
Quadropole Time-of-Flight mass spectrometer interfaced with an
HPLC Chip Cube. The samples were loaded onto an Ultra High
Capacity Chip (500 nL enrichment column, 75 μm × 150 mm analyti-
cal column). LC-MS/MS analysis was performed using a 90-minute
gradient ranging from 8% to 35% buffer B (100% acetonitrile, 0.8%
acetic acid). Full MS (MS1) data were acquired with a mass range of
400 to 1250 m/z and acquisition rate of 1 spectra/second. From
these data, an ion preferred list was generated with Agilent Mas-
sHunter Qualitative Software with the settings of 400 to 1250 m/z,
2+, 3+, 4+ and 5+ charge states, and spectra with 2 or more ions. The
directed Mass Spectrometry (dMS) was performed with the following
settings: a maximum of 10 ions per cycle, a narrow isolation width
(~1.3 atomic mass units), precursor masses dynamically excluded for
30 seconds after 8 MS/MS in a 30-second time window, and use of
the preferred ion list. Mass spectrometry capillary voltage and capil-
lary temperature settings were set to 1800 V and 330!C, respec-
tively. The infused reference mass of 1221.9906 was used to correct
precursor m/z masses each LC-MS/MS experiment.
For protein identification, the raw.d files were searched against the
UniProt mouse database using SpectrumMill Software version
B.04.01.141 (Agilent Technologies) with the following settings: precur-
sor mass tolerance of 25 parts per million (ppm), product mass tolerance
of 200 ppm, maximum of 2 miss cleavages, maximum charge state +5,
minimum parent mass shift −18 AMU and maximum parent mass shift
250 AMU. Search modifications included static carbamidomethylation
on cysteine residues (C = 57.02 AMU) and variable modifications for
oxidized methionine (M = 15.99 AMU), STY phosphorylation
(STY = 79.966 AMU) and ubiquitination (GG = 114.043 AMU). The
search results with a <1% false discovery rate were accepted and con-
verted to a scaffold file for data interpretation.
4.11 | Dimethyl labeling of peptides
Samples were reduced with DTT, alkylated with chloroacetamide
and then diluted for digestion first with Lys C and then Trypsin.
N-terminal amines and lysine residues were tagged using reductive
amination with isotopic variants of formaldehyde, as previously
described.54 MALDI analysis of the total peptide content for each
sample was then used to mix heavy and light samples at a 1:1 ratio.
4.12 | Comparative analysis of dimethyl-labeled
peptides
The University of Iowa Proteomic Facility performed dimethyl label-
ing and analysis of peptides in Figure 10. Each labeled (“light” and
“heavy”) peptide mixture was loaded on home-packed C-18 column
(Halo 2.7 μm particles: MDC) 100 μm intradermal × 10 cm using the
Thermo EZ nLC 1200 and analyzed on an Orbitrap Fusion Lumos
mass spectrometer (Thermo Fisher Scientific). For each injection, an
estimated 0.5 μg of total peptide was loaded and followed though a
120-minute linear gradient of 0% to 95% ACN in 0.1% formic acid.
Full MS (MS1) data were acquired with a mass range of 350 to
1500 m/z at a resolution of 60 000. The most abundant precursors
were selected among 2 to 8 charge state ions at a 2.0E5 threshold,
isolated by a multisegment quadrupole with a mass window of m/z
2, and sequentially subjected to both Collision-induced dissociation
(CID) and Higher-energy collisional dissociation (HCD) fragmentation.
Ions were then dynamically excluded for 30 seconds. Both MS2
channels were recorded as centroid and the MS1 survey scans were
recorded in profile mode.
Initial spectral searches were performed with MaxQuant v. 1.5.155
against UniprotKB entries for the organism Saccharomyces cerevisiae
NCBI taxonomy no. 559292 and with the Byonic (Protein Metrics) ver.
2.8.2. In either search an equal number of decoy entries were created
and searched simultaneously by reversing the original entries in the
Target databases. Discriminant scores were determined by Scaffold
Q + S ver. 4.7 (Proteome Software) at 2% False Discovery Rate (FDR).
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